Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Plos One|August 29, 2015
Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected PatientsJulia Dietz, Simone Susser, Caterina Berkowski, et al.Antiviral Therapy|March 4, 2014
HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapyBart Fevery, Simone Susser, Oliver Lenz, et al.Plos One|March 27, 2012
A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriersJohannes Vermehren, Jörn Lötsch, Simone Susser, et al.Journal of Clinical Microbiology|December 18, 2012
Second-generation Cobas AmpliPrep/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay designHeike Zitzer, Gabrielle Heilek, Karine Truchon, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2012
Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infectionJohannes Vermehren, Simone Susser, Annemarie Berger, et al.Antiviral Therapy|December 15, 2010
Screening for IL28B gene variants identifies predictors of hepatitis C therapy successAlexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.Plos One|November 14, 2014
Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis CSimone Susser, Eva Herrmann, Christian Lange, et al.Journal of Hepatology|January 16, 2014
Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infectionJohannes Vermehren, Alessio Aghemo, Karolin Falconer, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 20, 2011
Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevirSimone Susser, Johannes Vermehren, Nicole Forestier, et al.Journal of Hepatology|November 30, 2010
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patientsChristoph Sarrazin, Simone Susser, Alexandra Doehring, et al.Pageof 4